$49.61
-0.16 (-0.32%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-9.7% upside
Low Target
$31.89
Average Target
$44.79
High Target
$48.55
Current Price
$49.61
Current
$49.61
$49.61
Target
$44.79
$44.79
$31.89
$44.79 avg
$48.55
Scenario Analysis
Bear Case
$31.89
-35.7%
Low target
Base Case
$44.79
-9.7%
Avg target
Bull Case
$48.55
+-2.1%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$240.00
-79.3% from high
52-Week Low
$7.00
+608.7% from low
Target vs 52W High
$44.79
-81.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |